L-CsA in the Prevention of Bronchiolitis Obliterans Syndrome (BOS) in Lung Transplant (LT) Patients

This study has been terminated.
(Interim analysis results revealed substantial increase of patient number, with unfeasible study prolongation.)
Sponsor:
Information provided by (Responsible Party):
Pari Pharma GmbH
ClinicalTrials.gov Identifier:
NCT01334892
First received: April 11, 2011
Last updated: September 3, 2013
Last verified: September 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Estimated Study Completion Date: December 2013
  Primary Completion Date: July 2013 (Final data collection date for primary outcome measure)